SIGA Technologies, Inc
Industry
- Biotechnology
- Drug Discovery Technologies
- Genomics-Proteomics
- Large Molecule
- Antibodies
- Drug Discovery Technologies
- Pharmaceuticals
- Vaccines
Latest on SIGA Technologies, Inc
“We’re at an exciting juncture in medicine where the perceived scientific boundaries in treatment across therapeutic areas continue to dissolve.” These words from Jeffrey Jones , chief medical office
Following its declaration on 14 August that the spread of mpox (formerly known as monkeypox) within and beyond the Democratic Republic of the Congo (DRC) constitutes a public health emergency of inter
The emergence of a new more deadly strain of the mpox virus has led the World Health Organization to declare a global public health emergency and has created a surge in demand for vaccines and therapi
The World Health Organization (WHO) having this week declared mpox a public health emergency, now is not the time for a trial failure. Unfortunately SIGA Technologies, Inc ’s antiviral TPOXX (tecovir